Correlation Between Maat Pharma and Ekinops SA
Can any of the company-specific risk be diversified away by investing in both Maat Pharma and Ekinops SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maat Pharma and Ekinops SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maat Pharma SA and Ekinops SA, you can compare the effects of market volatilities on Maat Pharma and Ekinops SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maat Pharma with a short position of Ekinops SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maat Pharma and Ekinops SA.
Diversification Opportunities for Maat Pharma and Ekinops SA
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Maat and Ekinops is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Maat Pharma SA and Ekinops SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ekinops SA and Maat Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maat Pharma SA are associated (or correlated) with Ekinops SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ekinops SA has no effect on the direction of Maat Pharma i.e., Maat Pharma and Ekinops SA go up and down completely randomly.
Pair Corralation between Maat Pharma and Ekinops SA
Assuming the 90 days trading horizon Maat Pharma SA is expected to under-perform the Ekinops SA. In addition to that, Maat Pharma is 1.27 times more volatile than Ekinops SA. It trades about -0.11 of its total potential returns per unit of risk. Ekinops SA is currently generating about 0.04 per unit of volatility. If you would invest 351.00 in Ekinops SA on December 30, 2024 and sell it today you would earn a total of 18.00 from holding Ekinops SA or generate 5.13% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Maat Pharma SA vs. Ekinops SA
Performance |
Timeline |
Maat Pharma SA |
Ekinops SA |
Maat Pharma and Ekinops SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Maat Pharma and Ekinops SA
The main advantage of trading using opposite Maat Pharma and Ekinops SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maat Pharma position performs unexpectedly, Ekinops SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekinops SA will offset losses from the drop in Ekinops SA's long position.Maat Pharma vs. OSE Pharma SA | Maat Pharma vs. Abivax SA | Maat Pharma vs. Waga Energy SA | Maat Pharma vs. Inventiva SA |
Ekinops SA vs. Claranova SE | Ekinops SA vs. Derichebourg | Ekinops SA vs. Mersen SA | Ekinops SA vs. BigBen Interactive |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |